Company intelligence / Profile preview

Blue Water Science Advisors

Larkspur, California, United States

Ownership: Private
Development stage: Other

Overview

Blue Water Life Science Advisors manages a portfolio focused on life sciences companies, particularly in biotech, genomics, and diagnostics. Top holdings include Natera (NTRA), Adaptive Biotechnologies (ADPT), Guardant Health (GH), with a reported portfolio value of approximately $100-126 million as of recent 13F filings. The firm invests in public equities in healthcare sectors like diagnostics, biotech, and genomics.

Industry: Investors

Beyond the preview

Go deeper on Blue Water Science Advisors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blue Water Science Advisors.

Explore the full profile